EPSTEIN-BARR-VIRUS SM PROTEIN

被引:39
|
作者
COOK, ID [1 ]
SHANAHAN, F [1 ]
FARRELL, PJ [1 ]
机构
[1] ST MARYS HOSP,SCH MED,LUDWIG INST CANC RES,LONDON W2 1PG,ENGLAND
关键词
D O I
10.1006/viro.1994.1637
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The protein products of the Epstein-Barr Virus (EBV) BMLF1 open reading frame have been characterized in the early productive cycle in B95-8 and Akata cells. The SM protein derived from the spliced RNA joining BSLF2 to BMLF1 is much the most abundant protein. SM is a phosphoprotein in EBV-infected cells and can be phosphorylated in vitro with casein kinase II (CKII). Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein, the herpes simplex virus (HSV) ICP27 protein and the herpesvirus saimiri (HVS) open reading frame 57 protein. Site-directed mutagenesis of the consensus CKII site in EBV SM greatly reduced the in vitro phosphorylation of SM by CKII. The mechanism of transactivation by BMLF1 proteins has been controversial but SM was shown to transactivate gene expression from a CAT reporter construct by increasing the amount of cytoplasmic CAT mRNA. Mutagenesis of the CKII site in SM made no difference to the transactivation in this transient transfection assay. (C) 1994 Academic Press, Inc.
引用
收藏
页码:217 / 227
页数:11
相关论文
共 50 条
  • [21] EPSTEIN-BARR-VIRUS SEROEPIDEMIOLOGY IN CHINA
    ZENG, Y
    PI, GH
    DENG, H
    ZHANG, JM
    WANG, PC
    WOLF, H
    DETHE, G
    AIDS RESEARCH, 1986, 2 : S7 - S15
  • [22] EPSTEIN-BARR-VIRUS IN CARCINOMA OF THE CERVIX
    WONG, KY
    COLLINS, RJ
    SRIVASTAVA, G
    PITTALUGA, S
    CHEUNG, ANY
    WONG, LC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1993, 12 (03) : 224 - 227
  • [23] PROGRESS ON A VACCINE FOR EPSTEIN-BARR-VIRUS
    MARX, JL
    SCIENCE, 1986, 231 (4741) : 919 - 920
  • [24] EPSTEIN-BARR-VIRUS - NEW INSIGHTS
    KIEFF, E
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05): : 1323 - 1324
  • [25] NANOCRYSTALLINE EPSTEIN-BARR-VIRUS DECOYS
    KOSSOVSKY, N
    GELMAN, A
    SPONSLER, E
    MILLETT, D
    JOURNAL OF APPLIED BIOMATERIALS, 1991, 2 (04) : 251 - 259
  • [26] AN EPSTEIN-BARR-VIRUS TRANSFORMING PROTEIN ASSOCIATES WITH VIMENTIN IN LYMPHOCYTES
    LIEBOWITZ, D
    KOPAN, R
    FUCHS, E
    SAMPLE, J
    KIEFF, E
    MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (07) : 2299 - 2308
  • [27] EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN
    VONKA, V
    HIRSCH, I
    PROGRESS IN MEDICAL VIROLOGY, 1982, 28 : 145 - 179
  • [28] NASOPHARYNGEAL CARCINOMA AND EPSTEIN-BARR-VIRUS
    MONGIN, C
    GAILLARD, J
    HAGUENAUER, JP
    PIGNAT, C
    JOURNAL FRANCAIS D OTO-RHINO-LARYNGOLOGIE, 1986, 35 (04): : 189 - 194
  • [29] ASSOCIATION OF HEMOPHAGOCYTOSIS WITH EPSTEIN-BARR-VIRUS
    BORISCH, B
    VONLANTHEN, R
    HURWITZ, N
    LAISSUE, J
    LABORATORY INVESTIGATION, 1994, 70 (01) : A103 - A103
  • [30] Testing for an Impact of the Epstein-Barr-Virus
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (07): : 625 - 626